Effectiveness of 8-week glecaprevir/pibrentasvir for treatment-naive, compensated cirrhotic patients with chronic hepatitis C infection

Flamm SL, Kort J, Marx SE, et al. Effectiveness of 8-week glecaprevir/pibrentasvir for treatment-naive, compensated cirrhotic patients with chronic hepatitis C infection. Adv Ther. 2020;37(5):2267-2274.

Publication Type:

Journal Article

Authors:

Flamm, SL; Kort, J; Marx, SE; et, al

Source:

Adv Ther, Volume 37, Issue 5, p.2267-2274 (2020)

Cited On:

Export Citation:
RIS Format
Top